NCT06849492 2025-02-27
SHIFT-001
Fudan University
Phase 2 Not yet recruiting
Clinical Trials
4 trialsNCT05019690 2024-09-19
Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer
Fujian Cancer Hospital
Phase 1/2 Recruiting
NCT04927884 2024-06-12
A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies
ImmunityBio, Inc.
Phase 1/2 Terminated
NCT05686720 2023-01-17
Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer
First Affiliated Hospital of Shantou University Medical College
Phase EARLY_PHASE1 Unknown